We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Low strength

20 February 2018 By Lauren Silva Laughlin

The Cerberus-owned grocery chain is buying the $2.3 bln pharmacy for little premium. It’s a way for Albertsons to go public after aborted IPO efforts. But pharma’s problems and Rite Aid’s lack of scale offer a wobbly crutch for the buyer’s flat sales and declining EBITDA.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)